Clinical Trials Update: May 1, 2007

Growth Hormone Deficiencies/Abnormalities Irritable Bowel Syndrome (IBS) Infantile Spasms

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Growth Hormone Deficiencies/Abnormalities

Girls 3-10 years of age, and boys ages 3-11 are eligible for this 12-month study of growth hormone.

The research site is in Sacramento, Calif.

More information

Please see http://www.centerwatch.com/patient/studies/cat269.html.

-----

Irritable Bowel Syndrome (IBS)

Volunteers 18-79 who have been diagnosed with irritable bowel syndrome, have at least moderate abdominal pain or discomfort, and have had a sigmoidoscopy or colonoscopy with normal results in the past three years (or are willing to have these procedures) may qualify.

The research site is in New York City.

More information

Please see http://www.centerwatch.com/patient/studies/cat90.html.

-----

Infantile Spasms

This study will evaluate the safety and tolerability of a drug called ganaxolone in babies with infantile spasms. Children 4-24 months may be eligible.

The research site is in New York City.

More information

Please see http://www.centerwatch.com/patient/studies/cat798.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News